BERLIN: The first trial results of a coronavirus vaccine being developed by CureVac are expected in two months, German news agency dpa reported on Friday (Jun 19). 

CureVac, an unlisted German company, said this week that the first meaningful results could be available in September or October and, under favourable conditions, the vaccine could be approved by the middle of next year.